Myron W Smith, MD | |
310 Long Shoals Rd, Arden, NC 28704-8794 | |
(828) 252-7331 | |
Not Available |
Full Name | Myron W Smith |
---|---|
Gender | Male |
Speciality | Orthopedic Surgery |
Experience | 34 Years |
Location | 310 Long Shoals Rd, Arden, North Carolina |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1306886296 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207X00000X | Orthopaedic Surgery | 9500452 (North Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Kindred At Home | Asheville, NC | Home health agency |
Carepartners Home Health Services | Asheville, NC | Home health agency |
Encompass Health Home Health | Marion, NC | Home health agency |
Memorial Mission Hospital And Asheville Surgery Ce | Asheville, NC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Mission Health Community Multispecialty Providers Llc | 9537468574 | 577 |
News Archive
African American families not only share a higher risk for Type 2 diabetes, but many myths and misconceptions about the disease are often passed on from one generation to the next.
TapImmune Inc. announced that it has signed a Research and Technology License Option Agreement with Mayo Clinic, Rochester, MN, for the development of a smallpox vaccine technology. Research will be conducted by Gregory Poland M.D., at Mayo Clinic, to evaluate novel peptide antigens together with TapImmune's proprietary TAP technology. TapImmune also has an exclusive Option to the smallpox vaccine technology after research studies have been completed under the terms of the agreement.
Boston Scientific Corporation today announced its exclusive sponsorship and first enrollments of the MADIT-RIT clinical trial. This new trial follows in the tradition of three previous landmark trials: MADIT, MADIT II and MADIT-CRT, each exclusively sponsored by Boston Scientific and conducted under the leadership of Principal Investigator Arthur J. Moss, M.D., Professor of Medicine at the University of Rochester.
Bob Kerrey, the former Nebraska governor and U.S. senator, said on Wednesday he will run for his old Senate seat, raising the hopes of Democrats that they can keep control of the chamber this election year. ... Kerrey is the Democrat's best hope of keeping the Nebraska Senate seat because he is well known and can raise money, Jennifer Duffy, a senior editor at nonpartisan Cook Political Report, told Reuters earlier in the week. But Duffy predicted that some of Kerrey's positions, including his belief "that health care reform didn't go far enough, will not be popular in Nebraska."
The U.S. Food and Drug Administration has approved Gleevec (imatinib mesylate) for a new indication – keeping cancer from growing in patients following surgical removal of a gastrointestinal stromal tumor or GIST.
› Verified 7 days ago
Entity Name | Mission Health Community Multispecialty Providers Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1457719130 PECOS PAC ID: 9537468574 Enrollment ID: O20160426001883 |
News Archive
African American families not only share a higher risk for Type 2 diabetes, but many myths and misconceptions about the disease are often passed on from one generation to the next.
TapImmune Inc. announced that it has signed a Research and Technology License Option Agreement with Mayo Clinic, Rochester, MN, for the development of a smallpox vaccine technology. Research will be conducted by Gregory Poland M.D., at Mayo Clinic, to evaluate novel peptide antigens together with TapImmune's proprietary TAP technology. TapImmune also has an exclusive Option to the smallpox vaccine technology after research studies have been completed under the terms of the agreement.
Boston Scientific Corporation today announced its exclusive sponsorship and first enrollments of the MADIT-RIT clinical trial. This new trial follows in the tradition of three previous landmark trials: MADIT, MADIT II and MADIT-CRT, each exclusively sponsored by Boston Scientific and conducted under the leadership of Principal Investigator Arthur J. Moss, M.D., Professor of Medicine at the University of Rochester.
Bob Kerrey, the former Nebraska governor and U.S. senator, said on Wednesday he will run for his old Senate seat, raising the hopes of Democrats that they can keep control of the chamber this election year. ... Kerrey is the Democrat's best hope of keeping the Nebraska Senate seat because he is well known and can raise money, Jennifer Duffy, a senior editor at nonpartisan Cook Political Report, told Reuters earlier in the week. But Duffy predicted that some of Kerrey's positions, including his belief "that health care reform didn't go far enough, will not be popular in Nebraska."
The U.S. Food and Drug Administration has approved Gleevec (imatinib mesylate) for a new indication – keeping cancer from growing in patients following surgical removal of a gastrointestinal stromal tumor or GIST.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Myron W Smith, MD Po Box 602998, Charlotte, NC 28260-2998 Ph: () - | Myron W Smith, MD 310 Long Shoals Rd, Arden, NC 28704-8794 Ph: (828) 252-7331 |
News Archive
African American families not only share a higher risk for Type 2 diabetes, but many myths and misconceptions about the disease are often passed on from one generation to the next.
TapImmune Inc. announced that it has signed a Research and Technology License Option Agreement with Mayo Clinic, Rochester, MN, for the development of a smallpox vaccine technology. Research will be conducted by Gregory Poland M.D., at Mayo Clinic, to evaluate novel peptide antigens together with TapImmune's proprietary TAP technology. TapImmune also has an exclusive Option to the smallpox vaccine technology after research studies have been completed under the terms of the agreement.
Boston Scientific Corporation today announced its exclusive sponsorship and first enrollments of the MADIT-RIT clinical trial. This new trial follows in the tradition of three previous landmark trials: MADIT, MADIT II and MADIT-CRT, each exclusively sponsored by Boston Scientific and conducted under the leadership of Principal Investigator Arthur J. Moss, M.D., Professor of Medicine at the University of Rochester.
Bob Kerrey, the former Nebraska governor and U.S. senator, said on Wednesday he will run for his old Senate seat, raising the hopes of Democrats that they can keep control of the chamber this election year. ... Kerrey is the Democrat's best hope of keeping the Nebraska Senate seat because he is well known and can raise money, Jennifer Duffy, a senior editor at nonpartisan Cook Political Report, told Reuters earlier in the week. But Duffy predicted that some of Kerrey's positions, including his belief "that health care reform didn't go far enough, will not be popular in Nebraska."
The U.S. Food and Drug Administration has approved Gleevec (imatinib mesylate) for a new indication – keeping cancer from growing in patients following surgical removal of a gastrointestinal stromal tumor or GIST.
› Verified 7 days ago
Dr. Benjamin Joseph Davis, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2585 Hendersonville Rd, Arden, NC 28704 Phone: 828-258-8800 | |
Jason E Lang, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2585 Hendersonville Rd, Arden, NC 28704 Phone: 828-258-8800 Fax: 828-651-0026 | |
Laura Nicole Carlson, PA-C Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2585 Hendersonville Rd, Arden, NC 28704 Phone: 828-258-8800 | |
Dr. James Ryan Macdonell Iv, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 310 Long Shoals Rd, Arden, NC 28704 Phone: 828-252-7331 | |
Stephen M David, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 2585 Hendersonville Rd, Arden, NC 28704 Phone: 828-258-8800 Fax: 828-281-7178 |